Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 14.22% on an annualized basis producing an average annual return of 22.54%. Currently, Regeneron Pharmaceuticals ...

Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease ...

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

-Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

Their report, published in Advanced Photonics, introduces a metalens-based microscope that achieves both wide field of view and high-resolution imaging in a compact design. The researchers tackled ...

(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition commonly called "smoker's lung" failed a late-stage trial, although it ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed analyses from the Phase 3 C-POST trial, which evaluated PD-1 inhibitor Libtayo ® (cemiplimab) in patients with high-risk ...

You can use any image editing application, such as Microsoft Paint, to create a simple logo. However, if you want to create a complex, high resolution logo, you must use a full-featured graphics ...

The temperature variation may be tiny if there is a slight leakage. The thermal image must, therefore, have high optical and good temperature resolution. The aluminum surface presents issues for an ...

Buyers love the print and photo quality with duplex printing. Opinions vary on ease of use, WiFi performance, scanning, and overall value. Why choose this product? Perfect for high-quality photo ...